Back to top

Image: Bigstock featured highlights include: Verso, AECOM, Dillard's, Casey's General and Best Buy

Read MoreHide Full Article

For Immediate Release

Chicago, IL – October 10, 2018 - Stocks in this week’s article are Verso Corp. (VRS - Free Report) , AECOM (ACM - Free Report) , Dillard's Inc. (DDS - Free Report) , Casey's General Stores, Inc. (CASY - Free Report) and Best Buy Co., Inc. (BBY - Free Report) .

Recent Analyst Upgrades Bring These 5 Stocks in Focus

With the Q3 earnings season about to begin, investors look to add stocks that have the potential to surpass expectations. This is because an earnings beat generally leads to stock price appreciation.

However, the task of designing one’s portfolio with potential outperformers is anything but an easy one. In fact, equity market tricks are not easy to master with a number of stocks flooding the space at any point of time. The task becomes even more difficult when one tries to devise a winning portfolio without proper guidance.

Given time constraints, it is in the best interest of investors to be guided by experts in the field. In view of the above arguments, it can be safely stated that it is in the best interest of investors to pay heed to the opinion of brokers while deciding their course of action (buy, sell or hold) on a particular stock.

Broker Ratings Hold the Key

Broker ratings are backed by sound logic and are by no means arbitrary. Since brokers closely follow the stocks in their coverage, they revise earnings estimates only after carefully examining the pros and cons of an event for the concerned company.

Naturally, when investors see brokers revising their estimates or recommendation on a stock, they often assume that there is something in the stock that has attracted analyst attention. In fact, a rating upgrade generally leads to stock price appreciation.

Similarly, the price of a stock may plummet following a rating downgrade. In the event of estimates moving south, which can happen due to lower-than-expected earnings/modest sales or pipeline failure (for a biotech company), investors tend to offload the stock from their portfolio.

For the rest of this Screen of the Week article please visit at:

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

About Screen of the Week created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Contact: Jim Giaquinto


Phone: 312-265-9268


Visit: provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer.

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.